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Abstract: Introduction: Patients with acute renal colic need to choose between undergoing medical treatments and re-
ceiving interventions. The Aim of this study is to evaluate the outcomes of patients who are discharged from
emergency departments with ureteral stones lesser than 6 millimeters. In doing so, the effect of diagnostic treat-
ment approaches on clinical outcomes and referral rate is to be assessed. Methods: This study was performed on
patients with ureteral stones referred to emergency department of Shohadaye Tajrish Hospital between May2015
to June 2018. A checklist was filled out for each patient and it included their complete medical history, physical
examination results and paraclinical data. Patients were then studied for 4 weeks to determine referral times to
hospital and clinical outcomes. Results: 105 patients include 81 men (77.14%) with average age of 37.1±12.4
years were studied. The mean stone diameter was 4.2±2.1 mm. Most of ureteral stones were seen in the right-
hand side (60 percent). 71 patients (67.6%) did not have any history of nephrolithiasis and 73 (69.5%) did not
have positive family history for nephrolithiasis. Ureteral stones were still observed in 42 patients (40%) after
two weeks of studies and only one patient (1.1%) had stone in Ultrasound Imaging after 4 weeks of observations.
Conclusion: Most Patients (95%) with stones smaller than 6 mm responded to Medical Expulsive Therapy (MET)
after 4 weeks and passed spontaneously ureteral calculi.
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1. Introduction
Nephrolithiasis is a common and increasing problem world-
wide. Kidney stone is the third most prevalent disease of uri-
nary tract and its occurrence is growing progressively over
the past decades(1-3). The frequency of this condition is dif-
ferent in various regions. It is reported in 1-5% of Asia, 5-9%
of Europe, and 3% of Northern America. The rate of growing
urinary stone in normal populations is estimated to be 0.5%
per year in United States and Europe (4).
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Routine assessments in renal stone are often performed by
Ultrasonography. Computed Tomography (CT) scans with
low dose are the best choice in acute phase or when inter-
vention is needed (5, 6). Exact determination of maximum
stone size is very important in the clinical management for
the treatment of renal stones (5, 7). Throughout the current
decade, great advancements have been made in a number
of methods and technologies. This includes minimally in-
vasive treatment (8-10) and now, therapeutic options are in-
cluded in Extracorporeal Shock Wave Lithotripsy (ESWL)(8,
11), Percutaneous Nephrolithotomy (PCNL)(7, 12, 13), ret-
rograde intra renal surgery (RIRS) by laser (14), uretroscopic
lithotripsy, and stone disposal with Medical Exclusive Ther-
apy (MET)(7). Patients with acute renal colic need to choose
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between undergoing medical treatments and receiving inter-
ventions. Stone size is the key determining factor in this de-
cision making (5). In regards to the potential risks associ-
ated with this, it is not recommended to continue this con-
servative approach for more than 6 weeks (15). In most cases
encountered in the emergency department, pain is managed
by pain killers and patients are discharged with good general
condition in a short period of time, with the therapeutic sup-
port process set in place. On the other hand, in some cases,
patients need more hospitalization and receive more protec-
tive treatment (8).
According to the importance of renal stone management, the
aim of this study is to evaluate the outcomes of patients dis-
charged from emergency department with ureteral stones
lesser than 6 millimeters. In doing so, the effect of diagnostic
treatment approaches on clinical outcomes and referral rate
is to be assessed.
2. Methods
2.1. Study Population
This study was a prospective cohort work, which was per-
formed on patients with ureteral stones referred to emer-
gency department of Shohada-E-Tajrish hospital between
May 2015 to June 2018. Furthermore, patients with renal
abnormality, ureteral stone more than 6 mm, fever, history
of renal failure (serum creatinine âL’ě3 mg/dL), history of
ureteral obstruction, single kidney, and positive urinary cul-
ture, as well as pregnant women were excluded from this
study.
2.2. Study Design
A checklist was filled out for each patient and it included their
complete medical history and physical examinations. In an-
other checklist, a senior resident completed clinical vari-
ables such as the site and diameter of ureter stone (accord-
ing to sonographic and CT scan findings), pain score, pres-
ence or absence of hydronephrosis, hematologic tests, urine-
analysis, duration of pain, times of referral to emergency de-
partment until stone passage. After recording primary data,
patients were studied for 4 weeks to determine the times of
their referral to the hospital and their clinical outcomes. Dur-
ing the four weeks of study, seven patients with ureteral stone
and unrelieved pain who needed surgery were excluded. All
of the patient underwent Medical Expulsive Therapy (MET)
which included alpha-blockers and corticosteroids. Accord-
ing to clinical and diagnostic findings, stone passage time
and treatment trend was investigated, and the best treatment
was applied to reduce patients’ pain and anxiety. If indicated
as relevant, surgery or lithotripsy was evaluated and applied.
2.3. Ethical Considerations
The researchers and the personnel involved in this study car-
ried out all processes based on the considerations and stan-
dards of the ethical committee of Shahid Beheshti University
of Medical Sciences. Written informed consent was obtained
from all patients after explaining the risks, options and ben-
efits of the method as well as the whole study.
2.4. Statistical Analysis
We used SPSS software version 19.0 for data analysis in all
steps. Quantitative data were expressed as mean values and
standard deviation and qualitative variables as frequency
and percentage. P value lesser than 0.05 was considered as
significant.
3. Results
As mentioned above, 105 patients including 81 men (77.14%)
were present in this study. 90patients (85.7%) were located in
Tehran. The mean age of participants was 37.1±12.4 years.
Most of ureteral stones were seen in the right-hand side (60
percent). Lastly, other demographic data are listed in Ta-
ble 1. Amongst all the participants, 71 patients (67.6%) did
not have any history of nephrolithiasis and 73 (69.5%) did
not have positive family history for nephrolithiasis. Further-
more, 8 patients (7.6%) had fever at referral time. Presence
of nausea, vomiting, frequency, dysuria, and urinary reten-
tion was studied and regarded as associated symptoms. As
indicated throughout the study, most of the patients (32 pa-
tients, 30.5%) did not have any associated symptoms. Af-
ter that, nausea and vomiting together had more prevalence.
Pain scores were evaluated using the Numeric Rating Scale
(NRS) method and patients scored their pain from one (least
pain) to 10 (most severe pain). Pain in 100 patients (95.2%)
was 10, in 1 patient (1.1%) was 6, in 2 patients (1.9%) was 5,
and in 2 patients (1.9%) was 3. Throughout the study, 2 pa-
tients (1.9%) had their pain controlled by using only ketoro-
lac, 4 patients (3.8%) by only receiving morphine, and for 99
patients (94.3%) through the prescription of both ketorolac
and morphine. In the first two weeks, ureteral stone was still
observed in the sonography of 42 patients (40%). However,
after 4 weeks of studies, only one patient (1/1%) has their
stone present.
4. Discussion
Kidney and ureteral stones are still some of the most com-
mon urological problems around the world. (16, 17) These
conditions not only can cause severe pain in patients, but
also may lead to significant financial loss due to patients’ in-
ability to work as well as the high costs of their hospitaliza-
tion and the treatment of this condition. (18, 19) Accord-
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Table 1: Demographic and clinical characteristics of patients
Characteristics
Age, mean ± SD 37.1±12.4
BMI, mean ± SD 25.7±3.6




stone diameter, mm, mean ± SD 4.2±2.1







Cr, mean ± SD 1.1±0.3
GFR
60-89, n (%) 3(2.9%)
30-45, n%) 91(86.7%)
15-29, n (%) 10(9.5%)
<15, n (%) 1(1.1%)
U/A
WBC>105, n (%) 10(9.5%)
RBC>104, n (%) 15(14.3%)
WBC>105+ RBC>104, n (%) 30(28.3)
Abnormal urine PH 50(47.6)
ing to the finding of this study, in patients with stones less
than 6 millimeter in size, if there is no active indication of
stone removal, observation with periodic evaluations is an
optional treatment. These patients may be managed to fa-
cilitate stone removal within the period during which they
are being observed. (20) Monitoring the diagnostic treat-
ment system of health centers and hospitals, besides assess-
ing the success and failure rate by examining the secondary
complications as well as the frequency of patients’ referral to
the emergency departments, help to improve the overall ef-
fectiveness of therapy. (21) In doing that, with reduced cost
of treatment, the satisfaction rate amongst the patients will
increase (22). Hence, this study was designed to evaluate
patients with urinary tract stones and the outcome of their
treatments. In addition to the impact of the study design on
the demographic characteristics of the population, many en-
vironmental factors lead to differences between the statisti-
cal communities of the various studies. (23) For example, the
impact of patients’ gender as well as their location, lifestyle,
nutrition, etc., affects the distribution of gender and age of
the statistical community. (24) In several articles, it has been
mentioned that the incidence of kidney and ureteral stones
in male patients and those who are diagnosed with obesity
with high BMI is more than females and those with aver-
age BMI. (25) As far as this study is concerned, the preva-
lence of male patients is more than that of females, and the
mean BMI of patients is above the normal level. Some stud-
ies revealed that obesity, diabetes, hypertension, arthroscle-
rosis, and chronic kidney disease (CKD) may increase the
risk of urinary tract stones. (26) In the previous study, how-
ever, 87.6% of patients did not mention any history of disor-
ders which they may have experienced. In saying that, due
to the multifactorial nature of the occurrence of diseases in
the science of medicine, especially urinary stones (27), our
finding cannot be considered as contradictory to the previ-
ous studies. In the present study, stones located in middle
third of the ureter were more frequent and the upper third of
the ureter were less prevalent. (28) According to Moosanejad
et al. (25) the highest prevalence of stones was in the mid-
dle calyx and the least prevalence was is in the upper ure-
thra. In this paper, the location of the least prevalence was
consistent with that of Moosanejad’s finding. More preva-
lence of calyx stones in the study of Moosanejad was due to
various factors involving the characteristics of the statistical
society and the difference in the number of patients stud-
ied, and it is acceptable. In 43 patients (41%) the diameter
of the stone was less than 3 mm, and in 44 patients (41.9%),
the diameter of the stone was greater than 3 mm. In con-
trast to this investigation, other studies did not use the cut
off value to report the size of the stone, but instead, reported
the mean size value. In addition, most articles are based on
the evaluation of various therapeutic methods and invasive
devices, so the reported average size of the stones is higher
than that of this study. For example, in Fayed et al., (16) aver-
age stone size was reported to be 1.44 cm in patients or in the
study of Moosanejad (11) this variable was 3.99 cm. Accord-
ing to the findings of the CT scans of the patients, most of
them had mild hydronephrosis. However, ultrasonography
results recommended that most of the patients did not have
hydronephrosis. This is largely due to the value of CT Scan in
comparison with ultrasonography. In this investigation, the
average level of Creatinine (Cr) was 1.18, the mean uric acid
level was 5.8, the mean urea level was 19.83, the mean cal-
cium level was 9.37, the mean phosphorus level was 3.6, and
the average level of hemoglobin was 14.39. Considering the
epidemiological and the cross-sectional nature of the study
without any intervention, the laboratory findings were mea-
sured once and were part of the characteristics of the study
population. In other studies, there are often two methods of
treatment and intervention in patients with renal stones, and
there are not any studies which investigate laboratory find-
ings. Ultimately, to put the key findings of this project in one
place, it can be said that the majority of patients with ureter
stones are male and their BMI is higher than normal. A posi-
tive personal or family history of renal stone is very important
in the formation of stone and the creation of this condition.
The existence of disorders like diabetes mellitus and hyper-
tension can increase the chances of urinary stones’ forma-
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tion. Pain and fever are common symptoms of this disorder,
and the most common associations are nausea and vomiting.
Morphine plays a significant role to control pain and nausea
in patients and is more effective and useful than other sub-
stance. In 95% of the cases, patients with stones less than 6
mm in size were relieved of their condition after 4 weeks of
studies and relevant treatments.
5. Conclusion
In conclusion, it can be proposed that most of the patients
with urolithiasis are male and their BMI levels are higher than
those of normal individuals. The presence of diseases such
as diabetes mellitus and hypertension can lead to higher
rates of stone formation. Furthermore, experiencing pain
is a common symptom of this disorder, and the most com-
mon complications are nausea and vomiting. It can also be
suggested that the prescription of Morphine is an effective
way to control pain and nausea in patients who experience
this condition. Most Patients with stones smaller than 6 mm
would respond to MET for a duration of 4 weeks and pass
spontaneously ureteral calculi.
6. Limitations
It is recommended for other cohort studies to be carried out
with a larger number of patients in order to further investi-
gate this condition and henceforth confirm our results.
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